New Data from the Framingham Heart Study Supports PAT Technology to Diagnose Early Cardiovascular Disease
ORLANDO, Fla., Nov. 7 /PRNewswire-USNewswire/ -- Results from the
latest generation of the long-term Framingham Heart Study were presented
today here at the American Heart Association's Scientific Sessions. The
data indicates a strong relationship between decreased microvascular
function and c...
Economy is Driving Many Osteoporotic Women to Retire Later - But Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease
...rofessional about their disease."
Women like Olmsted Falls resident pat
Lindamood know all too well the impacts of PMO. Lindamood realized she had ...ical, emotional and financial disruption of a broken bone in my life," said pat
Lindamood. "Women who suffer from osteoporosis like me must be proactive ab...
Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R)
BIAL (head office)
Heparin Use Prior to Endoscopic Vein Harvest Improves Graft Patency in Off-Pump Coronary Artery Bypass Patients
...ficacy of this procedure," said Dr. Poston.
"We are encouraged by the results of this study and see it as a true advance in patient care," said pat
Walsh, Chief Operating Officer of the Cardiac Surgery division of MAQUET. "As a leader in EVH, MAQUET is committed to helping physicians continue to ...
New Research Reveals Unforeseen Side Effect of the Breast Cancer Movement
...ast Cancer Symposium.
Other authors include Dr. Jennifer Griggs ( University of Michigan ); Dr. Larry
Norton (Memorial Sloan-Kettering Cancer Center); pat
Nogar, Dr. Paul Gilman,
Dr. Jen Sabol, Dr. Zonera Ali, Dr. Ned Carp (all from Lankenau Hospital); Dr.
Harvey Karp ( UCLA ); and Dr. Graham Colditz ( W...
Late-Breaking Data Highlighting Research Advances in Several Blood Disorders to Be Presented At the American Society of Hematology Annual Meeting
... start of the study, 18 patients had abnormal mean pat
scores (1.33 ± 0.17) and nine patients had normal mean pat
scores (2.09 ± 0.31).
More than one-third (67 percent) of patients with abnormal pat
scores achieved statistically significant dose-dep...
BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
...mg/kg; p=0.075). -- SCD patients with an abnormal pat
scores of less than or equal to 1.67 at baseli...0 and 20 mg/kg). -- The mean endothelial function pat
score improved from the abnormal to the normal range (>1.67) in SCD patients with an abnormal pat
score at baseline. -- Improvement in endothel...
First Breast Cancer Patient Receives Treatment in National Electronic Brachytherapy Registry Launched by Three Physician Societies
...BrS with a focus on breast surgery are:
Michael Kinney, MD, Northwest Breast Care, Henry Kuerer, MD Anderson, Helen
Pass, MD, Columbia University, and pat
Whitworth, MD, Nashville Breast
Center and Vanderbilt University.
About Electronic Brachytherapy
Cleared for accelerated treatment of early stage ...
Supportive Oncology Services Accrues One Million Cancer Patient Self-Reported Assessments
...ore focused and
productive physician/patient encounter. "The PACE System prompts patients
to tell me things they might otherwise forget," according to pat
Medical Oncologist with Hematology-Oncology Centers of the Northern Rockies
in Billings, Montana. "Additionally, patients seem more comforta...
TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
...ify and track
everything that is going on with a person who is part of a case management,
disease management, or prevention/wellness program," remarks pat
RN, MEd, Vice President of Clinical Services at TCS Healthcare Technologies
and who also headed up the team that developed AcuCare. She adds...
September is National Pain Awareness Month
linked to opioid use. "Chronic pain disrupts an individual's life and can add tremendous
physical, emotional and economic burden," said Mary pat
director, National Pain Foundation. "Chronic pain is one of the great
hidden crises of our time, made all the more urgent by the fa...
Micromet and MedImmune Present Data From Preclinical Study of New
BiTE Molecule Targeting CEA
...ions,+1-301-398-4320; or Micromet: Company, Chris Schnittker,
SVP & CFO,+1-267-242-3151, ; or Investors,Susan Noonan,
+1-212-966-3650, , or Media, pat
Publication Confirms that EpCAM, the Target for Two of Micromet's
Product Candidates, Is Overexpressed on Cancer Stem Cells of
... or otherwise.
CONTACT: Chris Schnittker, SVP & CFO of Micromet, Inc.,
+1-240-752-1421,; or Investors, Susan Noonan,+1-212-966-3650, , or
Garrison,+1-917-322-2567, , both for Micromet, Inc.